PM8002

· Biotheus Inc.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for PM8002, covering 2024-12-05 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC [Phase 2]